Ignite Creation Date:
2025-12-24 @ 11:33 PM
Ignite Modification Date:
2026-01-14 @ 8:34 AM
Study NCT ID:
NCT06767956
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-06-04
First Post:
2025-01-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Golcadomide and Nivolumab in Patients With Non-Hodgkin Lymphoma With Refractory Disease After Chimeric Antigen T-cell Therapy
Sponsor:
Natalie Galanina
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-06-30
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-04-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-04-30
Completion Date Type:
ESTIMATED
First Submit Date:
2025-01-05
First Submit QC Date:
None
Study First Post Date:
2025-01-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-30
Last Update Post Date:
2025-06-04
Last Update Post Date Type:
ACTUAL